Metabolic inflammation: Role of cytokines in the crosstalk between adipose tissue and liver1

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 11, 2013, Pages 867-872

  Gerner, Romana R ^a   Wieser, Verena ^a   Moschen, Alexander R ^a   Tilg, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adipocytokines; Adipose tissue inflammation; Inflammation; Insulin resistance; Metabolism; Non alcoholic fatty liver disease

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 1; INTERLEUKIN 6; MULTIPROTEIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; B LYMPHOCYTE; CELL INFILTRATION; CHRONIC INFLAMMATION; FATTY LIVER; HUMAN; MACROPHAGE; MONOCYTE; MORBID OBESITY; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; LIVER; RECEPTOR CROSS-TALK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885437946     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0050     Document Type: Review

References (59)

1. Aguirre, V., Uchida, T., Yenush, L., Davis, R., and White, M.F. 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275(12): 9047-9054. doi:10.1074/jbc.275.12.9047. PMID:10722755.
2. Anderson, E.K., Gutierrez, D.A., and Hasty, A.H. 2010. Adipose tissue recruitment of leukocytes. Curr. Opin. Lipidol. 21(3): 172-177. doi:10.1097/MOL. 0b013e3283393867. PMID:20410821
3. Aparicio-Vergara, M., Hommelberg, P.P., Schreurs, M., Gruben, N., Stienstra, R., Shiri-Sverdlov, R., et al. 2012. Tumor necrosis factor receptor 1 gain-offunction mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. Hepatology, 57(2): 566-576. doi: 10.1002/hep.26046. PMID:22941955.
4. Bastard, J.P., Maachi, M., Van Nhieu, J.T., Jardel, C., Bruckert, E., Grimaldi, A., et al. 2002. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87(5): 2084-2089. doi:10.1210/jc.87.5.2084. PMID:11994345.
5. Crespo, J., Cayon, A., Fernandez-Gil, P., Hernandez-Guerra, M., Mayorga, M., Dominguez-Diez, A., et al. 2001. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology, 34(6): 1158-1163. doi:10.1053/jhep.2001.29628. PMID: 11732005.
6. Dandona, P., Weinstock, R., Thusu, K., Abdel-Rahman, E., Aljada, A., and Wadden, T. 1998. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83(8): 2907-2910. doi:10.1210/jc. 83.8.2907. PMID:9709967.
7. Di Gregorio, G.B., Hensley, L., Lu, T., Ranganathan, G., and Kern, P.A. 2004. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am. J. Physiol. Endocrinol. Metab. 287(1): E182-E187. doi:10.1152/ajpendo.00189.2003. PMID: 15191885.
8. Dinarello, C.A. 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood, 117(14): 3720-3732. doi:10.1182/blood-2010-07-273417. PMID:21304099.
9. Donath, M.Y., and Shoelson, S.E. 2011. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11(2): 98-107. doi:10.1038/nri2925. PMID:21233852.
10. Donath, M.Y., Boni-Schnetzler, M., Ellingsgaard, H., Halban, P.A., and Ehses, J.A. 2010. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol. Metab. 21(5): 261-267. doi:10. 1016/j.tem.2009.12.010. PMID:20096598.
11. Fain, J.N. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74: 443-477. doi:10.1016/S0083-6729(06)74018-3. PMID: 17027526.
12. Flores, M.B., Rocha, G.Z., Damas-Souza, D.M., Osorio-Costa, F., Dias, M.M., Ropelle, E.R., et al. 2012. Obesity-induced increase in tumor necrosis factoralpha leads to development of colon cancer in mice. Gastroenterology, 143(3): 741-753 e741-e744. doi:10.1053/j.gastro.2012.05.045. PMID:22677195.
13. Granowitz, E.V., Clark, B.D., Mancilla, J., and Dinarello, C.A. 1991. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J. Biol. Chem. 266(22): 14147-14150. PMID: 1830582.
14. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259(5091): 87-91. doi:10.1126/science.7678183. PMID:7678183.
15. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., and Spiegelman, B.M. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science, 271(5249): 665-668. doi:10.1126/science.271.5249.665. PMID:8571133.
16. Hulsmans, M., Geeraert, B., De Keyzer, D., Mertens, A., Lannoo, M., Vanaudenaerde, B., et al. 2012. Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. PLoS One, 7(1): e30414. doi:10.1371/journal.pone.0030414. PMID:22272346.
17. Jones, J.R., Barrick, C., Kim, K.A., Lindner, J., Blondeau, B., Fujimoto, Y., et al. 2005. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 102(17): 6207-6212. doi:10.1073/pnas.0306743102. PMID:15833818.
18. Kamari, Y., Shaish, A., Vax, E., Shemesh, S., Kandel-Kfir, M., Arbel, Y., et al. 2011. Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J. Hepatol. 55(5): 1086-1094. doi:10.1016/j.jhep.2011.01.048. PMID:21354232.
19. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., et al. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116(6): 1494-1505. doi:10.1172/JCI26498. PMID:16691291.
20. Kern, P.A., Saghizadeh, M., Ong, J.M., Bosch, R.J., Deem, R., and Simsolo, R.B. 1995. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95(5): 2111-2119. doi:10.1172/JCI117899. PMID:7738178.
21. Kopp, H.P., Kopp, C.W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., et al. 2003. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler. Thromb. Vasc. Biol. 23(6): 1042-1047. doi:10.1161/01.ATV.0000073313. 16135.21. PMID:12714437.
22. Lagathu, C., Yvan-Charvet, L., Bastard, J.P., Maachi, M., Quignard-Boulange, A., Capeau, J., et al. 2006. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia, 49(9): 2162-2173. doi:10.1007/s00125-006-0335-z. PMID:16865359.
23. Lee, S., Zhang, H., Chen, J., Dellsperger, K.C., Hill, M.A., and Zhang, C. 2012. Adiponectin abates diabetes-induced endothelial dysfunction by suppressing oxidative stress, adhesion molecules, and inflammation in type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 303(1): H106-H115. doi: 10.1152/ajpheart.00110.2012. PMID:22561304.
24. Li, P., Fan, W., Xu, J., Lu, M., Yamamoto, H., Auwerx, J., et al. 2011. Adipocyte NCoR knockout decreases PPARgamma phosphorylation and enhances PPARgamma activity and insulin sensitivity. Cell, 147(4): 815-826. doi:10.1016/j.cell.2011.09.050. PMID:22078880.
25. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., et al. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8(7): 731-737. doi:10.1038/nm724. PMID: 12068289.
26. Matos, M.F., Lourenco, D.M., Orikaza, C.M., Gouveia, C.P., and Morelli, V.M. 2012. Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6. Metab. Syndr. Relat. Disord. In press. In press.
27. McGillicuddy, F.C., Harford, K.A., Reynolds, C.M., Oliver, E., Claessens, M., Mills, K.H., et al. 2011. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes, 60(6): 1688-1698. doi:10.2337/db10-1278. PMID:21515850.
28. Meier, C.A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., and Dayer, J.M. 2002. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J. Clin. Endocrinol. Metab. 87(3): 1184-1188. doi:10.1210/jc.87.3.1184. PMID:11889184.
29. Membrez, M., Ammon-Zufferey, C., Philippe, D., Aprikian, O., Monnard, I., Mace, K., et al. 2009. Interleukin-18 protein level is upregulated in adipose tissue of obese mice. Obesity (Silver Spring), 17(2): 393-395. doi:10.1038/oby. 2008.535. PMID:19039317.
30. Moschen, A.R., Molnar, C., Geiger, S., Graziadei, I., Ebenbichler, C.F., Weiss, H., et al. 2010. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut, 59(9): 1259-1264. doi:10.1136/gut.2010.214577. PMID:20660075.
31. Moschen, A.R., Molnar, C., Enrich, B., Geiger, S., Ebenbichler, C.F., and Tilg, H. 2011. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol. Med. 17(7-8): 840-845. PMID: 21394384.
32. Moschen, A.R., Wieser, V., and Tilg, H. 2012. Adiponectin: key player in the adipose tissue-liver crosstalk. Curr. Med. Chem. 19(32): 5467-5473. doi:10. 2174/092986712803833254. PMID:22876924.
33. Nold, M.F., Nold-Petry, C.A., Zepp, J.A., Palmer, B.E., Bufler, P., and Dinarello, C.A. 2010. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11(11): 1014-1022. doi:10.1038/ni.1944. PMID:20935647.
34. O'Hara, A., Lim, F.L., Mazzatti, D.J., and Trayhurn, P. 2012. Stimulation of inflammatory gene expression in human preadipocytes by macrophageconditioned medium: upregulation of IL-6 production by macrophagederived IL-1beta. Mol. Cell. Endocrinol. 349(2): 239-247. doi:10.1016/j.mce. 2011.10.031. PMID:22079434.
35. Okamoto, Y., Ishii, S., Croce, K., Katsumata, H., Fukushima, M., Kihara, S., et al. 2013. Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques. Atherosclerosis, 226(2): 373-377. doi:10.1016/j.atherosclerosis.2012.12.012. PMID:23290299.
36. Osborn, O., and Olefsky, J.M. 2012. The cellular and signalling networks linking the immune system and metabolism in disease. Nat. Med. 18(3): 363-374. doi:10.1038/nm.2627. PMID:22395709.
37. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., et al. 1999. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100(25): 2473-2476. doi:10.1161/01. CIR.100.25.2473. PMID:10604883.
38. Peyrin-Biroulet, L., Gonzalez, F., Dubuquoy, L., Rousseaux, C., Dubuquoy, C., Decourcelle, C., et al. 2012. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut, 61(1): 78-85. doi:10.1136/gutjnl-2011-300370. PMID:21940721.
39. Pihlajamaki, J., Kuulasmaa, T., Kaminska, D., Simonen, M., Karja, V., Gronlund, S., et al. 2012. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J. Hepatol. 56(3): 663-670. doi:10.1016/j.jhep.2011.10.005. PMID:22027586.
40. Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J.Y., Ko, H.J., et al. 2008. A stress signalling pathway in adipose tissue regulates hepatic insulin resistance. Science, 322(5907): 1539-1543. doi:10.1126/science.1160794. PMID:19056984.
41. Sahin-Efe, A., Katsikeris, F., and Mantzoros, C.S. 2012. Advances in adipokines. Metabolism, 61(12): 1659-1665. doi:10.1016/j.metabol.2012.09.001. PMID: 23021039.
42. Schipper, H.S., Prakken, B., Kalkhoven, E., and Boes, M. 2012. Adipose tissueresident immune cells: key players in immunometabolism. Trends Endocrinol. Metab. 23(8): 407-415. doi:10.1016/j.tem.2012.05.011. PMID:22795937.
43. Stadlmayr, A., Aigner, E., Steger, B., Scharinger, L., Lederer, D., Mayr, A., et al. 2011. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J. Intern. Med. 270(1): 41-49. doi:10.1111/j.1365-2796.2011.02377.x. PMID:21414047.
44. Stickel, F., and Hellerbrand, C. 2010. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut, 59(10): 1303-1307. doi:10.1136/gut.2009.199661. PMID:20650925.
45. Stienstra, R., Joosten, L.A., Koenen, T., van Tits, B., van Diepen, J.A., van den Berg, S.A., et al. 2010. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12(6): 593-605. doi:10.1016/j.cmet.2010.11.011. PMID:21109192.
46. Stienstra, R., Tack, C.J., Kanneganti, T.D., Joosten, L.A., and Netea, M.G. 2012. The inflammasome puts obesity in the danger zone. Cell Metab. 15(1): 10-18. doi:10.1016/j.cmet.2011.10.011. PMID:22225872.
47. Tilg, H., and Diehl, A.M. 2000. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343(20): 1467-1476. doi:10.1056/NEJM200011163432007. PMID:11078773.
48. Tilg, H., and Diehl, A.M. 2011. NAFLD and extrahepatic cancers: have a look at the colon. Gut, 60(6): 745-746. doi:10.1136/gut.2011.239392. PMID:21454382.
49. Tilg, H., and Moschen, A.R. 2010. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology, 52(5): 1836-1846. doi:10.1002/hep.24001. PMID:21038418.
50. Tilg, H., Vannier, E., Vachino, G., Dinarello, C.A., and Mier, J.W. 1993. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178(5): 1629-1636. doi:10.1084/jem.178.5.1629. PMID:7693853.
51. Tilg, H., Dinarello, C.A., and Mier, J.W. 1997. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today, 18(9): 428-432. doi:10. 1016/S0167-5699(97)01103-1. PMID:9293158.
52. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., and Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 389(6651): 610-614. doi:10.1038/39335. PMID:9335502.
53. Vernochet, C., Mourier, A., Bezy, O., Macotela, Y., Boucher, J., Rardin, M.J., et al. 2012. Adipose-specific deletion of tfam increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab. 16(6): 765-776. doi:10.1016/j.cmet.2012.10.016. PMID:23168219.
54. Wallenius, V., Wallenius, K., Ahren, B., Rudling, M., Carlsten, H., Dickson, S.L., et al. 2002. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8(1): 75-79. doi:10.1038/nm0102-75. PMID:11786910.
55. Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., et al. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116(1): 115-124. doi:10.1172/JCI24335. PMID:16341265.
56. Wolf, A.M., Wolf, D., Rumpold, H., Enrich, B., and Tilg, H. 2004. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 323(2): 630-635. doi:10.1016/j.bbrc. 2004.08.145. PMID:15369797.
57. Wong, V.W., Wong, G.L., Tsang, S.W., Fan, T., Chu, W.C., Woo, J., et al. 2011. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut, 60(6): 829-836. doi:10.1136/gut.2011.237974. PMID:21339204.
58. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., et al. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423(6941): 762-769. doi:10.1038/nature01705. PMID:12802337.
59. Younis, S., Rosner, I., Rimar, D., Boulman, N., Rozenbaum, M., Odeh, M., et al. 2013. Weight change during pharmacological blockade of interleukin-6 or tumor necrosis factor-alpha in patients with inflammatory rheumatic disorders: A 16-week comparative study. Cytokine, 61(2): 353-355. doi: 10.1016/j. cyto.2012.11.007. PMID:23228348.